A first-in-human feasibility study to evaluate the safety (and short term effectiveness) of the autologous GrOwnValve transcatheter pulmonary heart valve (GECT-DZHK28)

In the GECT-DZHK28 study of the German Center for Cardiovascular Research, scientists are ivestigating a heart valve replacement made of the patient's own tissue in humans, which is unique worldwide according to the current state of knowledge. The…

1 Min
More

Personalized treatment for peanut allergy

Oral immunotherapy helps many children with peanut allergy – but for some, it can also trigger severe allergic reactions. In the journal Allergy, a team led by Young-Ae Lee explains what might be behind these differences and how treatment could…

3 Min
More

Early Stage Start-ups & Growth Scale-ups for Frontiers Health's Discovery Sessions

Deadline: August 28, 2025

2 Min
More

Advancing Protein Simulation with Machine Learning

An international team led by Einstein Professor Cecilia Clementi in the Department of Physics at Freie Universität Berlin introduces a breakthrough in protein simulation. The study, published in the July 18, 2025, issue of Nature Chemistry, presents…

2 Min
More

AssistMe secures €5.2 million in growth capital for its care platform alea

Digital assistance system relieves nursing staff by providing real-time notifications of incontinence and movement, among other things

4 Min
More

Leibniz Senate confirms excellent development of ATB

The joint funding of the Leibniz Institute for Agricultural Engineering and Bioeconomy (ATB) by the federal and state governments is to be continued. The Senate of the Leibniz Association published its positive recommendation for continued funding on…

3 Min
More

Award for excellent communication of animal research

DRFZ once again receives quality label from “Understanding Animal Experiments”

1 Min
More

Green Health Accelerator - Applications now open

Apply until July 30, 2025

1 Min
More

Eckert & Ziegler: Outstanding Training Quality Once Again Awarded

Eckert & Ziegler SE (ISIN DE0005659700) has been recognized by the Berlin Chamber of Industry and Commerce (IHK) for the exceptional quality of its training program for the fourth time in a row. The Berlin-based healthcare company already held the…

2 Min
More

Biosynth Expands Berlin Site with a New Commercial Bioconjugation Suite

The new suite extends GMP bioconjugate production for intermediates and active pharmaceutical ingredients from early clinical phase through to late clinical phases and commercial supply.

1 Min
More
Show more items